JP2021152043A5 - - Google Patents

Download PDF

Info

Publication number
JP2021152043A5
JP2021152043A5 JP2021099839A JP2021099839A JP2021152043A5 JP 2021152043 A5 JP2021152043 A5 JP 2021152043A5 JP 2021099839 A JP2021099839 A JP 2021099839A JP 2021099839 A JP2021099839 A JP 2021099839A JP 2021152043 A5 JP2021152043 A5 JP 2021152043A5
Authority
JP
Japan
Prior art keywords
group
oxygen
nitrogen
sulfur
membered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021099839A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021152043A (ja
Filing date
Publication date
Priority claimed from JP2018543061A external-priority patent/JP6900385B2/ja
Application filed filed Critical
Publication of JP2021152043A publication Critical patent/JP2021152043A/ja
Publication of JP2021152043A5 publication Critical patent/JP2021152043A5/ja
Priority to JP2022176130A priority Critical patent/JP2023012519A/ja
Pending legal-status Critical Current

Links

JP2021099839A 2015-11-06 2021-06-16 トリテルペンサポニン類似物 Pending JP2021152043A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022176130A JP2023012519A (ja) 2015-11-06 2022-11-02 トリテルペンサポニン類似物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562252296P 2015-11-06 2015-11-06
US62/252,296 2015-11-06
US201562268837P 2015-12-17 2015-12-17
US62/268,837 2015-12-17
JP2018543061A JP6900385B2 (ja) 2015-11-06 2016-11-04 トリテルペンサポニン類似物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018543061A Division JP6900385B2 (ja) 2015-11-06 2016-11-04 トリテルペンサポニン類似物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022176130A Division JP2023012519A (ja) 2015-11-06 2022-11-02 トリテルペンサポニン類似物

Publications (2)

Publication Number Publication Date
JP2021152043A JP2021152043A (ja) 2021-09-30
JP2021152043A5 true JP2021152043A5 (enExample) 2022-03-10

Family

ID=58662549

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018543061A Active JP6900385B2 (ja) 2015-11-06 2016-11-04 トリテルペンサポニン類似物
JP2021099839A Pending JP2021152043A (ja) 2015-11-06 2021-06-16 トリテルペンサポニン類似物
JP2022176130A Pending JP2023012519A (ja) 2015-11-06 2022-11-02 トリテルペンサポニン類似物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018543061A Active JP6900385B2 (ja) 2015-11-06 2016-11-04 トリテルペンサポニン類似物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022176130A Pending JP2023012519A (ja) 2015-11-06 2022-11-02 トリテルペンサポニン類似物

Country Status (12)

Country Link
US (5) US20180327436A1 (enExample)
EP (2) EP3370730A4 (enExample)
JP (3) JP6900385B2 (enExample)
KR (1) KR20180077180A (enExample)
CN (2) CN108778289B (enExample)
AU (1) AU2016349693B2 (enExample)
CA (1) CA3003483C (enExample)
CL (1) CL2018001192A1 (enExample)
IL (3) IL286493B (enExample)
SG (2) SG11201803594TA (enExample)
WO (1) WO2017079582A1 (enExample)
ZA (1) ZA201802891B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015184451A1 (en) * 2014-05-30 2015-12-03 Memorial Sloan-Kettering Cancer Center Minimal saponin analogues, synthesis and use thereof
IL286493B (en) 2015-11-06 2022-07-01 Memorial Sloan Kettering Cancer Center Triterpene saponin analogues, methods of producing same, compositions comprising same and uses thereof
IL269963B2 (en) * 2017-04-13 2024-09-01 Adjuvance Tech Inc Triterpene saponin synthesis, intermediates and adjuvant combinations
CN110582282A (zh) * 2017-04-25 2019-12-17 佐剂技术公司 三萜皂苷类似物
US20200164065A1 (en) * 2017-04-25 2020-05-28 Adjuvance Technologies, Inc. Triterpene saponin analogues
JP2020536946A (ja) * 2017-10-16 2020-12-17 アジュバンス・テクノロジーズ・インコーポレーテッド トリテルペンサポニン類似物
AU2020379738A1 (en) 2019-11-05 2022-04-14 Adjuvance Technologies, Inc. Varicella zoster
WO2021195024A1 (en) * 2020-03-23 2021-09-30 Adjuvance Technologies, Inc. Adjuvant compounds, salt forms, and formulations
AU2021276401A1 (en) 2020-05-19 2022-12-15 Othair Prothena Limited Multi-epitope vaccine for the treatment of Alzheimer's disease
CN116472055A (zh) 2020-08-07 2023-07-21 欧萨尔普罗席纳有限公司 治疗阿尔兹海默氏病的多表位疫苗
WO2023056089A1 (en) 2021-10-03 2023-04-06 Eisai R&D Management Co., Ltd. Immunological adjuvant formulations comprising tlr4 agonist e6020
WO2023081505A1 (en) * 2021-11-08 2023-05-11 Adjuvance Technologies, Inc. Adjuvant compounds and formulations
EP4190359A1 (en) 2021-12-03 2023-06-07 Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE Saponin-based adjuvants and vaccines
EP4466278A1 (en) 2022-01-19 2024-11-27 Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE Saponin-based adjuvants and vaccines
CN117106004B (zh) * 2022-05-17 2026-06-19 北京科兴中维生物技术有限公司 三萜皂苷化合物及其制备方法及应用
WO2024218268A1 (en) 2023-04-20 2024-10-24 Asociación Centro De Investigación Cooperativa En Biociencias-Cic Biogune Saponin derivatives as adjuvants and photoaffinity probes
WO2024261351A2 (en) 2024-05-08 2024-12-26 Vaccine Formulation Institute Ch Ltd. Immunologically active saponin fractions and adjuvant formulations

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5341202B2 (enExample) 1974-03-12 1978-11-01
US5231112A (en) 1984-04-12 1993-07-27 The Liposome Company, Inc. Compositions containing tris salt of cholesterol hemisuccinate and antifungal
US5916588A (en) 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US4769239A (en) 1984-08-21 1988-09-06 Merck & Co., Inc. Vaccine against varicella-zoster virus
US4684479A (en) 1985-08-14 1987-08-04 Arrigo Joseph S D Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
US6759057B1 (en) 1986-06-12 2004-07-06 The Liposome Company, Inc. Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
IE60901B1 (en) 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US6406713B1 (en) 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
US5583112A (en) 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
AU598958B2 (en) 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
US5215680A (en) 1990-07-10 1993-06-01 Cavitation-Control Technology, Inc. Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
PT651789E (pt) 1992-07-17 2002-05-31 Merck & Co Inc Metodo para a prevencao de zoster ou alivio de neuralgia pos-herpetica relacionada com varicela
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
ATE252372T1 (de) 1996-08-23 2003-11-15 Sequus Pharm Inc Liposome enthaltend cisplatin
US6056973A (en) 1996-10-11 2000-05-02 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method of preparation
WO1998016201A1 (en) 1996-10-11 1998-04-23 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method
AU725257B2 (en) 1996-10-15 2000-10-12 Transave, Inc. N-acyl phosphatidylethanolamine-mediated liposomal drug delivery
US6080725A (en) * 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
EP1279401B1 (en) 1997-09-05 2008-01-09 GlaxoSmithKline Biologicals S.A. Oil in water emulsions containing saponins
US6262029B1 (en) * 1998-08-14 2001-07-17 Galenica Pharmaceuticals, Inc. Chemically modified saponins and the use thereof as adjuvants
AU7085400A (en) 1999-09-02 2001-03-26 Antigenics, Inc. Compositions of immunostimulatory polymers and saponin adjuvants and uses thereof
GB0401239D0 (en) 2004-01-21 2004-02-25 Molecularnature Ltd Adjuvant compositions
GB0504436D0 (en) 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0700562D0 (en) * 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
CN101678091A (zh) 2007-05-24 2010-03-24 葛兰素史密丝克莱恩生物有限公司 冷冻干燥的抗原组合物
JP2011507816A (ja) 2007-12-21 2011-03-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム マラリア用ワクチン
KR102085687B1 (ko) * 2008-04-08 2020-03-06 슬로안-케테링인스티튜트퍼캔서리서치 트리테르펜 사포닌, 그의 합성 방법, 및 그의 용도
KR20110009157A (ko) 2008-04-16 2011-01-27 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
GB0910046D0 (en) 2009-06-10 2009-07-22 Glaxosmithkline Biolog Sa Novel compositions
US9950062B2 (en) 2009-09-02 2018-04-24 Glaxosmithkline Biologicals Sa Compounds and compositions as TLR activity modulators
KR20140033127A (ko) 2011-05-17 2014-03-17 글락소스미스클라인 바이오로지칼즈 에스.에이. 스트렙토코쿠스 뉴모니애에 대한 백신
US20130309273A1 (en) 2012-05-17 2013-11-21 Kimberly Hassett Thermostable Vaccine Compositions and Methods of Preparing Same
KR102374576B1 (ko) 2011-05-17 2022-03-15 솔리제닉스, 인크. 열안정성 백신 조성물 및 그의 제조방법
WO2014124860A1 (en) 2013-02-14 2014-08-21 Boehringer Ingelheim International Gmbh Specific pde4b-inhibitors for the treatment of diabetes mellitus
US20150037374A1 (en) 2013-07-31 2015-02-05 Csl Limited Anti-tumor compositions and uses thereof
WO2015184451A1 (en) 2014-05-30 2015-12-03 Memorial Sloan-Kettering Cancer Center Minimal saponin analogues, synthesis and use thereof
CA2970840A1 (en) 2014-12-18 2016-06-23 Glaxosmithkline Biologicals S.A. Vaccine composition comprising truncated varicella zoster virus glycoprotein e antigen
IL286493B (en) 2015-11-06 2022-07-01 Memorial Sloan Kettering Cancer Center Triterpene saponin analogues, methods of producing same, compositions comprising same and uses thereof
ES2944947T3 (es) 2015-12-17 2023-06-27 Memorial Sloan Kettering Cancer Center Variantes de triterpeno-saponina, métodos de síntesis y uso de las mismas
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
IL269963B2 (en) 2017-04-13 2024-09-01 Adjuvance Tech Inc Triterpene saponin synthesis, intermediates and adjuvant combinations
CN110582282A (zh) 2017-04-25 2019-12-17 佐剂技术公司 三萜皂苷类似物
US20200164065A1 (en) 2017-04-25 2020-05-28 Adjuvance Technologies, Inc. Triterpene saponin analogues
EP3678695A1 (en) 2017-09-08 2020-07-15 Infectious Disease Research Institute Liposomal formulations comprising saponin and methods of use
JP2020536946A (ja) 2017-10-16 2020-12-17 アジュバンス・テクノロジーズ・インコーポレーテッド トリテルペンサポニン類似物
TW201946650A (zh) 2018-03-12 2019-12-16 美商詹森藥物公司 針對腹內感染之疫苗
AU2020379738A1 (en) 2019-11-05 2022-04-14 Adjuvance Technologies, Inc. Varicella zoster

Similar Documents

Publication Publication Date Title
US12037355B2 (en) Triterpene saponin analogues
US20260115281A1 (en) Triterpene saponin analogues
JP7177082B2 (ja) トリテルペンサポニン類似物
US20230357300A1 (en) Triterpene saponin synthesis, intermediates and adjuvant combinations
HK40042493A (en) Triterpene saponin analogues
HK40016648A (en) Triterpene saponin analogues
HK40016652A (zh) 三萜皂苷类似物
HK1260769A1 (en) Triterpene saponin analogues
HK1260769B (en) Triterpene saponin analogues